Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jeanelle McSurdy-Freed"'
Autor:
Michael D. Spengler, Ramona Plant, Kaushik Raha, Hong Lin, Hongyi Yu, Cynthia M. Rominger, Ralph A. Rivero, Michael L. Moore, Mary Ann Hardwicke, Michael D. Schaber, Jeanelle McSurdy-Freed, Karl F. Erhard, Juan I. Luengo, Junya Qu
Publikováno v:
ACS Medicinal Chemistry Letters. 4:230-234
A series of novel [3a,4]dihydropyrazolo[1,5a]pyrimidines were identified, which were highly potent and selective inhibitors of PI3Kβ. The template afforded the opportunity to develop novel SAR for both the hinge-binding (R3) and back-pocket (R4) sub
Autor:
Shufang Zhao, Laura M. Storck, Charles B. Davis, Jeanelle McSurdy-Freed, Robert W. Coatney, Kendall S. Frazier, Catherine X. Hu, Jon Renninger, Tracy L. Gales, Kevin French, Emile Chen
Publikováno v:
Toxicologic Pathology. 38:691-702
Several multikinase angiogenesis inhibitors demonstrate mitochondrial and/or cardiovascular toxicity, suggesting an on-target pharmacologic effect. To evaluate whether cardiotoxicity is directly related to vascular endothelial growth factor receptor
Autor:
Hong Lin, Charles B. Davis, Kaushik Raha, Ralph A. Rivero, Michael D. Schaber, Jeanelle McSurdy-Freed, Mary Ann Hardwicke, Karl F. Erhard, James F. Mack, Ren Xie, Michael D. Spengler, Ramona Plant, Cynthia M. Rominger, Junya Qu, Rosanna Tedesco, Jennifer L. Ariazi, Juan I. Luengo, Mark J. Schulz, Michael D. Squire, Christian S. Sherk, Jin Zeng
A novel thiazolopyrimidinone series of PI3K-beta selective inhibitors has been identified. This chemotype has provided an excellent tool compound, 18, that showed potent growth inhibition in the PTEN-deficient breast cancer cell line MDA-MB-468 under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace88350b0677b6d5e549d1aab456577
https://europepmc.org/articles/PMC4025772/
https://europepmc.org/articles/PMC4025772/
Autor:
Sanchez Robert, Jeanelle McSurdy-Freed, Hongyi Yu, Michael L. Moore, Rosanna Tedesco, Mary Ann Hardwicke, Karl F. Erhard, Ralph A. Rivero, Kaushik Raha, Michael D. Spengler, Juan I. Luengo, Ramona Plant, Hong Lin, Michael D. Schaber, Cynthia M. Rominger
Publikováno v:
Bioorganicmedicinal chemistry letters. 22(9)
A series of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones with excellent enzyme inhibition, improved isoform selectivity, and excellent inhibition of downstream phosphorylation of AKT has been identified. Several compounds in the series demonstrated pote
Autor:
Michael D. Spengler, Rosanna Tedesco, Sanchez Robert, Michael D. Schaber, Ramona Plant, Hong Lin, Mary Ann Hardwicke, Karl F. Erhard, James F. Mack, Kaushik Raha, Ralph A. Rivero, Cynthia M. Rominger, Juan I. Luengo, Mark J. Schulz, Jeanelle McSurdy-Freed, Ren Xie, Jin J. Zeng
Publikováno v:
Bioorganicmedicinal chemistry letters. 22(6)
A series of PI3K-beta selective inhibitors, imidazo[1,2-a]-pyrimidin-5(1H)-ones, has been rationally designed based on the docking model of the more potent R enantiomer of TGX-221, identified by a chiral separation, in a PI3K-beta homology model. Syn
Autor:
Ramesh Bambal, Hong Xiang, Jeanelle McSurdy-Freed, Ganesh S. Moorthy, Charles B. Davis, Erin D. Hugger, Chao Han, Santiago Ferrer, Domingo Gargallo
Publikováno v:
Journal of pharmaceutical sciences. 95(12)
GW844520 is a potent and selective inhibitor of the cytochrome bc1 complex of mitochondrial electron transport in P. falciparum, the parasite primarily responsible for the mortality associated with malaria worldwide. GW844520 is fully active against
Autor:
Richard Wooster, Kristin K. Brown, Deping Chai, Mariela Colón, Jennifer L. Ariazi, Chad Quinn, Sharon Sweitzer, Nino Campobasso, Subhas J. Chakravorty, Gregory M. Waitt, Tony Shaw, Kevin J. Duffy, Roland S. Annan, Jacques Briand, Nathan Gaul, Christian S. Sherk, Elizabeth A. Davenport, Jeanelle McSurdy-Freed, Kelvin Nurse, Anthony J. Jurewicz, Dean E. McNulty, Gilbert F. Scott, Angela Smallwood, James P. Villa, Hong Lu, Paru Nuthulaganti, Julia Billiard, Christopher S Dodson, Jessica L. Schneck, Lisa Miller, Seth A. Gilbert
Publikováno v:
Cancer Research. 73:5418-5418
Many cancer cells generate energy by rapidly converting glucose to lactate in the cytosol, a process termed aerobic glycolysis. This metabolic phenotype is recognized as one of the hallmarks of cancer and is enabled by lactate dehydrogenase (LDH), wh
Autor:
Joel Greshock, Mariela Colón, Chad Quinn, Gilbert F. Scott, Gordon B. Mills, Richard Wooster, Gregory M. Waitt, Shaw Antony N, Roland S. Annan, Junping Jing, Kevin J. Duffy, Lisa A. Orband-Miller, Jacques Briand, Hong Lu, Julia Billiard, Seth A. Gilbert, Jeanelle McSurdy-Freed, Christopher S Dodson, Jessica L. Schneck, Jennifer B. Dennison, Deping Chai
Publikováno v:
Cancer & Metabolism
Background Most normal cells in the presence of oxygen utilize glucose for mitochondrial oxidative phosphorylation. In contrast, many cancer cells rapidly convert glucose to lactate in the cytosol, a process termed aerobic glycolysis. This glycolytic